“We are pleased that Bosnalijek recognized Pharmamed as a partner on the domestic market because Bosnia and Herzegovina (BiH) in the pharmaceutical industry certainly has what to offer what the European and world medical, herbal medical and dietary markets want”, Sanjin Kotlica, the director of Pharmamed, said.
Commenting on Bosnalijek’s entry into the ownership structure of Pharmamed d.o.o. Travnik, Kotlica said that although their products are already present on the European, Middle East and African markets, this will be a significant step forward to opening up new opportunities for over 200 products, including medicines, medical products, dietary products and cosmetics.
“We believe that together with Bosnalijek, we will make a stronger step forward in the existing markets. We are sure that cooperation with such a large pharmaceutical company, which has recently recorded a steady increase in production and income and entered to the vast Russian market, real opportunities for placing Pharmhamed products are ahead, which will greatly facilitate the growth and development of our company,” Kotlica says.
(Source: Radiosarajevo.ba)
